With surveys demonstrating that care disparities in atopic dermatitis (AD) may exist among pediatric patients with the chronic skin condition, investigators set out to determine AD’s prevalence by sociodemographic subgroup.
Researchers found disparities in the diagnosis and risk of eczema over a 20-year period among patients from 6 ethnic/racial populations, according to cross-sectional study findings published in JAMA Dermatology.
Using US National Health Interview Survey data from 1997 to 2018, study authors determined eczema prevalence in the past year overall, by age (0-5, 6-10, 11-17 years), by sex, by race (American Indian or Alaskan Native, Asian, Black, multiracial, White), and by Hispanic ethnicity.
“Surveys suggest that disparities in care may exist between sociodemographic subgroups,” the study authors wrote. “Research on the prevalence of eczema in children in the United States is limited.”
They specifically asked a question to determine the prevalence of eczema or skin allergy during the past 12 months.
Via the unweighted count, there were 260,888 cases of eczema overall. By age, most of these appeared among children ages 11 to 17 years (n = 105,291), followed by 0 to 5 years (n = 88,523) and 6 to 10 years (n = 67,074). In addition, more cases were seen among male vs female patients (134,196 vs 126,692), and the most cases (75.1%) were seen among White patients. Seventy-nine percent of the patients overall did not report Hispanic ethnicity.
There was a universal rise in eczema prevalence from 1997 to 2010 for all age groups, but children aged 11 to 17 years were the only ones among whom prevalence rose for the entire study period. Overall, eczema prevalence rose from 7.9% (95% CI, 7.3%-8.5%) of cases in 1997 to 12.6% (95% CI, 11.6%-13.6%) in 2018; this corresponded to an average annual percentage change (AAPC) of 2.8%.
Prevalence increases were close to equal among male and female patients. Cases among males rose from 7.7% (95% CI, 7.0%-8.5%) to 12.2% (95% CI, 11.0%-13.6%), for an AAPC of 2.7%, and cases among female patients rose from 8.1% (95% CI, 7.3-9.0) to 12.9% (95% CI, 11.6%-14.3%), for an AAPC of 2.8%.
Among the patient races evaluated, cases rose the most among multiracial patients between 1997 and 2018:
Prevalence also rose slightly more among those who did not report Hispanic ethnicity compared with those who did: Cases in this subanalysis rose from 8.3% (95% CI, 7.7%-9.0%) to 13.2% (95% CI, 12.1%-14.4%) and 5.6% (95% CI, 4.7%-6.6%) to 10.6% (95% CI, 9.0%-12.4%), respectively, for corresponding AAPCs of 2.7% vs 2.5%.
Data also show the following:
“This study found an increasing trend in the prevalence of eczema from 1997 to 2018 for noninstitutionalized children in the United States, with significant differences between race and ethnicity,” the study authors concluded. “Specifically, larger yearly AAPCs in children with eczema in Black and multiracial subgroups (compared with White) were identified.”
The recommend more research among pediatric racial and ethnic groups, especially because, as they highlight, findings from a 2019 study do not show an association between African genetic ancestry and risk of atopic dermatitis compared with European ancestry, “suggesting that contextual variables such as socioeconomic status, environment, and health care access and quality may be factors in eczema prevalence.”
Reference
Choragudi S, Yosipovitch G. Trends in the prevalence of eczema among US children by age, sex, race, and ethnicity from 1997 to 2018. JAMA Dermatol. 2023;159(4):454-456. doi:10.1001/jamadermatol.2022.6647
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Health Equity, Accessibility Essential to Supporting Women Affected by Hemophilia
May 10th 2024Due to often being overlooked as only carriers of hemophilia, the review authors sought to highlight the needs of female caretakers for patients with the disorder and the possibility of women themselves being affected by it.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen